Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
A phase 2 trial of Romidepsin in Alveolar soft part sarcoma, Angiosarcoma, Epithelioid sarcoma, Chondrosarcoma, Osteosarcoma and Leiomyosarcoma, run by National Cancer Institute (NCI), completed.
Overview
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma is a phase 2 interventional study registered as NCT00112463 by National Cancer Institute (NCI), with 40 participants recorded, started 2005-01-07 and reaching its primary completion in 2008-10-23. Interventions recorded: romidepsin. Conditions recorded: Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Gastrointestinal Stromal Tumor, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Adult Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma.
Linked to the drug Romidepsin because the registry names it among its interventions and Alveolar soft part sarcoma, Angiosarcoma, Epithelioid sarcoma, Chondrosarcoma, Osteosarcoma and Leiomyosarcoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)
Shares Romidepsin and the tag pipeline.
- TrialIntratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
Shares Angiosarcoma and the tag pipeline.
- TrialA Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.
Shares Epithelioid sarcoma and the tag pipeline.
- TrialRandomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
Shares Romidepsin and the tag pipeline.
- TrialEvaluate the Safety and Clinical Activity of HH2853
Shares Epithelioid sarcoma and the tag pipeline.
- TrialZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Shares Leiomyosarcoma and the tag pipeline.
- TrialLu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Shares Osteosarcoma and the tag pipeline.
- TrialCombination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Shares Osteosarcoma and the tag pipeline.